Molecular mechanisms and potential interventions during aging-associated sarcopenia.
Abstract
Sarcopenia, a common condition observed in the elderly, presenting a significant public health challenge due to its high prevalence, insidious onset and diverse systemic effects. Despite ongoing research, the precise etiology of sarcopenia remains elusive. Aging-related processes, which included inflammation, oxidative stress, compromised mitochondrial function and apoptosis, have been implicated in its development. Notably, effective pharmacological treatments for sarcopenia are currently lacking, highlighting the necessity for a deeper understanding of its pathogenesis and causative factors to enable proactive interventions. This article is aimed to provide an extensive overview of the pathogenesis of sarcopenia, along with a summary of current treatment and prevention strategies.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper addresses sarcopenia, a condition associated with aging, and discusses its underlying mechanisms and potential interventions. While it provides valuable insights into the pathogenesis of sarcopenia, it primarily focuses on treatment and prevention strategies rather than addressing the root causes of aging itself. Therefore, while it is relevant to longevity research, its impact is limited as it does not propose significant advancements in understanding or intervening in the aging process.
Author of this paper? Send a correction.